Safety and Tolerability of Anti-IL-20 in Subjects With Rheumatoid Arthritis
Clinical trial NCT01038674 · COMPLETED
Trial details
- NCT number
- NCT01038674
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-02-01
- Primary completion
- 2010-12-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.